Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants diagnosed as diabetic based on clinical history, biochemical markers and/or use of oral hypoglycemic agents (OHA) 2. Participants diagnosed as dyslipidemic based on biochemical markers and/or taking any anti-dyslipidemic medicine including statins 3. Participant of any gender 4. Participants in the age group 19 years to 70 years
Exclusion criteria
Exclusion criteria: 1. Participants who are already on Homoeopathic medicines and do not wish to discontinue their ongoing treatment 2. Pregnant and lactating mothers 3. Participants not willing to give their consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in total serum Cholesterol (mg/dL)Timepoint: At the end of 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Change in High Density Lipoprotein Cholesterol (mg/dL) 2) Change in Low Density Lipoprotein Cholesterol (mg/dL) 3) Change in serum Triglycerides (mg/dL) 4) Change in fasting blood sugar (mg/dL) 5) Change in glycated hemoglobin (%) 6) Change in body weight (kg) 7) Change in blood pressure (mmHg)Timepoint: At the end of 12 weeks | — |
Countries
India
Contacts
P P Savani University